z-logo
Premium
First report of cross resistance to silver and antibiotics in Klebsiella pneumoniae isolated from patients and polluted water in Tunisia
Author(s) -
Ben Miloud Samar,
Ali Md Muntasir,
Boutiba Ilhem,
Van Houdt Rob,
Chouchani Chedly
Publication year - 2021
Publication title -
water and environment journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 37
eISSN - 1747-6593
pISSN - 1747-6585
DOI - 10.1111/wej.12665
Subject(s) - klebsiella pneumoniae , microbiology and biotechnology , multiple drug resistance , antibiotics , antibiotic resistance , pathogen , biology , silver nitrate , drug resistance , plasmid , escherichia coli , chemistry , gene , biochemistry , nuclear chemistry
Klebsiella pneumoniae , ubiquitously found in a variety of environmental sources, is an important pathogen in burn wounds and nosocomial infections. Burn wounds have been commonly treated with silver compounds, which are also used in a multitude of (non)medical products. As the latter increased silver discharge into different environments, we evaluated and compared silver resistance in K. pneumoniae isolates collected from patients hospitalized at the Charles‐Nicolle hospital (Tunis, Tunisia) with isolates collected from different metal polluted waters in the north and south of Tunisia. All K. pneumoniae isolates harboured bla TEM‐1 and bla SHV‐1 . In addition, all clinical isolates showed a multidrug phenotype and harboured the bla CTX‐M‐15 , bla OXA‐1 and bla NDM‐1 . Furthermore, all isolates showed resistance to silver nitrate. The silver resistance determinant, screened via the silE gene, was located for all isolates on a large plasmid with a size similar to pMG101. This study showed cross‐resistance between silver and beta‐lactams in clinical as well as environmental K. pneumoniae isolates from Tunisia and showed for the first time that NDM‐1‐producing K. pneumoniae developed resistance to silver.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here